Hualan Biological Bacterin Inc.

Shenzhen Stock Exchange:301207.SZ

Sector

🏥 Health Care

Industries

💉 Vaccines

🧬 Biotechnology

Location

China

Market Cap

USD 1.39 B

Share Price

USD 2.30

Avg Daily Volume

2,280,983

Change (1 day)

-0.33%

Change (1 year)

-9.61%

Change (YTD)

-4.24%

Hualan Biological Bacterin Inc. Price to Book Ratio (P/B) on June 16, 2025: 1.68

Hualan Biological Bacterin Inc. Price to Book Ratio (P/B) is 1.68 on June 16, 2025, a -2.99% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Hualan Biological Bacterin Inc. 52-week low Price to Book Ratio (P/B) is 2.22 on June 16, 2025, which is 32.14% above the current Price to Book Ratio (P/B).
Hualan Biological Bacterin Inc. 52-week low Price to Book Ratio (P/B) is 1.50 on June 16, 2025, which is -11.02% below the current Price to Book Ratio (P/B).
Hualan Biological Bacterin Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 1.70.

Daily

From:

To:

Zoom:

Key data

Date	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield

Shenzhen Stock Exchange: 301207.SZ

Hualan Biological Bacterin Inc.

CEO	Ms. Wenjue An
IPO Date	Feb. 18, 2022
Location	China
Headquarters	No. 1, Westlands Road
Employees	748
Sector	🏥 Health Care
Industries Vaccines 🧬 Biotechnology

Description

Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China. Hualan Biological Bacterin Inc. was formerly a subsidiary of Hualan Biological Engineering Inc.